These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9080633)

  • 1. Paroxetine (Paxil) overdose: a pediatric focus.
    Myers LB; Krenzelok EP
    Vet Hum Toxicol; 1997 Apr; 39(2):86-8. PubMed ID: 9080633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin re-uptake inhibitor warnings and trends in exposures reported to poison control centres in Texas.
    Forrester MB
    Public Health; 2008 Dec; 122(12):1356-62. PubMed ID: 18706667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRI safety in overdose.
    Barbey JT; Roose SP
    J Clin Psychiatry; 1998; 59 Suppl 15():42-8. PubMed ID: 9786310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine and galactorrhea.
    Bonin B; Vandel P; Sechter D; Bizouard P
    Pharmacopsychiatry; 1997 Jul; 30(4):133-4. PubMed ID: 9271780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on paroxetine.
    Green B
    Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine.
    Tang SW; Helmeste D
    Expert Opin Pharmacother; 2008 Apr; 9(5):787-94. PubMed ID: 18345955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children.
    Klein-Schwartz W; Benson BE; Lee SC; Litovitz T
    Clin Toxicol (Phila); 2012 Jun; 50(5):418-23. PubMed ID: 22506805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paroxetine (paxil): use in clinical practice].
    Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
    Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
    Strobel M; Warnke A; Roth M; Schulze U
    Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S; Bellantuono C
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.
    Kelly CM; Juurlink DN; Gomes T; Duong-Hua M; Pritchard KI; Austin PC; Paszat LF
    BMJ; 2010 Feb; 340():c693. PubMed ID: 20142325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.
    Nelson LS; Erdman AR; Booze LL; Cobaugh DJ; Chyka PA; Woolf AD; Scharman EJ; Wax PM; Manoguerra AS; Christianson G; Caravati EM; Troutman WG
    Clin Toxicol (Phila); 2007 May; 45(4):315-32. PubMed ID: 17486478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
    Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
    Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of nefazodone.
    Peak DA
    Ann Emerg Med; 1997 Oct; 30(4):551. PubMed ID: 9326874
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical management of perinatal depression: focus on paroxetine.
    Newport DJ; Stowe ZN
    Psychopharmacol Bull; 2003; 37 Suppl 1():148-66. PubMed ID: 14566197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased perioperative blood loss during treatment with paroxetine].
    Sewnath ME; van Hillegersberg R; Koopman MM; Levi MM; Gouma DJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1800-2. PubMed ID: 12369443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.